search
Back to results

Effects of Travoprost on Neovascular Glaucoma

Primary Purpose

Neovascular Glaucoma

Status
Withdrawn
Phase
Not Applicable
Locations
Brazil
Study Type
Interventional
Intervention
Travoprost
Sponsored by
Federal University of São Paulo
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional treatment trial for Neovascular Glaucoma focused on measuring Neovascular glaucoma, Travoprost

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Neovascular glaucoma of known cause
  • Older than 18 years
  • Previously submitted to retinal photocoagulation
  • Under medical treatment to glaucoma

Exclusion Criteria:

  • Need of antiglaucomatous surgery
  • Previous ocular surgery in the last 6 months
  • Pregnancy

Sites / Locations

  • Federal University of São Paulo

Outcomes

Primary Outcome Measures

Intraocular pressure

Secondary Outcome Measures

Inflammation

Full Information

First Posted
February 27, 2007
Last Updated
June 21, 2011
Sponsor
Federal University of São Paulo
search

1. Study Identification

Unique Protocol Identification Number
NCT00441181
Brief Title
Effects of Travoprost on Neovascular Glaucoma
Official Title
Effects of Travoprost on Neovascular Glaucoma
Study Type
Interventional

2. Study Status

Record Verification Date
February 2007
Overall Recruitment Status
Withdrawn
Study Start Date
January 2008 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
December 2008 (Anticipated)

3. Sponsor/Collaborators

Name of the Sponsor
Federal University of São Paulo

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Prostaglandin analogues have not been used in the treatment of neovascular glaucoma because of suspicious lack of efficacy. This study aims at assessing the effect of travoprost on neovascular glaucoma.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Neovascular Glaucoma
Keywords
Neovascular glaucoma, Travoprost

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Double
Allocation
Randomized
Enrollment
40 (Anticipated)

8. Arms, Groups, and Interventions

Intervention Type
Drug
Intervention Name(s)
Travoprost
Primary Outcome Measure Information:
Title
Intraocular pressure
Secondary Outcome Measure Information:
Title
Inflammation

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Neovascular glaucoma of known cause Older than 18 years Previously submitted to retinal photocoagulation Under medical treatment to glaucoma Exclusion Criteria: Need of antiglaucomatous surgery Previous ocular surgery in the last 6 months Pregnancy
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Luiz A Melo Jr, MD
Organizational Affiliation
Federal University of São Paulo
Official's Role
Principal Investigator
Facility Information:
Facility Name
Federal University of São Paulo
City
São Paulo
ZIP/Postal Code
04023-900
Country
Brazil

12. IPD Sharing Statement

Learn more about this trial

Effects of Travoprost on Neovascular Glaucoma

We'll reach out to this number within 24 hrs